Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

Clinical trial NCT00350818 · COMPLETED

Trial details

NCT number: NCT00350818
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Leukemia

Start date: 2005-10-01
Primary completion: 2010-08-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.